2017
DOI: 10.1016/j.jceh.2017.01.028
|View full text |Cite
|
Sign up to set email alerts
|

Results of Portosystemic Shunt Embolization in Selected Patients with Cirrhosis and Recurrent Hepatic Encephalopathy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

0
9
0

Year Published

2021
2021
2021
2021

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(9 citation statements)
references
References 0 publications
0
9
0
Order By: Relevance
“…A significant reduction in serum ammonia was noted with no recurrence of encephalopathy in any of these patients. 17 However, there are very few reports of these techniques in patients after liver transplantation. Baimakhanov et al 18 reported a case of a 52-year-old LDLT recipient with a large SMV-IVC PSS.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…A significant reduction in serum ammonia was noted with no recurrence of encephalopathy in any of these patients. 17 However, there are very few reports of these techniques in patients after liver transplantation. Baimakhanov et al 18 reported a case of a 52-year-old LDLT recipient with a large SMV-IVC PSS.…”
Section: Discussionmentioning
confidence: 99%
“…In another study from our Institute, 17 five patients with cirrhosis underwent BRTO or PARTO for recurrent HE and the presence of lieno‐renal ( n = 4) or meso‐caval shunts ( n = 1). Sclerosant was used in two patients, endovascular occlusion plugs in two patients, and a combination of both in one patient.…”
Section: Discussionmentioning
confidence: 99%
“…Generally, balloon-occluded retrograde transvenous obliteration (BRTO) is effective for managing solitary gastric varices or recurrent hepatic encephalopathy with a portosystemic shunt (17,18). Furthermore, there are some data showing that BRTO improves the liver function via an increase in the portal venous flow volume after shunt occlusion (17,19).…”
Section: Discussionmentioning
confidence: 99%
“…6). 3,[22][23][24][25] Pooled analysis of the published Indian studies revealed survival rate at 1 year among patients undergoing BRTO of 97% (95% CI: 0.91 to 1.0) and 98% (95% CI:0.89 to 1.0) by fixed and random effect models, respectively (►Fig. 7).…”
Section: Discussionmentioning
confidence: 99%
“…7). 3,[22][23][24][25] To our knowledge, there are two other large studies from the Indian subcontinent, describing the role of BRTO in patients with bleeding GVs or HE. 3,25 The sclerosant used by authors in both these studies was a mixture of air, STS, and lipiodol in a ratio 3:2:1.…”
Section: Discussionmentioning
confidence: 99%